Zosano Pharma is a biopharmaceutical company, develops products based on the transdermal delivery technology.
Zosano Pharma focuses on creating better products with its innovative drug delivery technology. Zosano's objective is to discover and develop therapeutic drug candidates that address large unmet medical needs or have a significant potential for commercialization.It was founded in 2006 and headquartered in Fremont, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 6, 2015 | Post-IPO Debt | $14.99M | 1 | Hercules Capital | — | Detail |
Sep 19, 2013 | Debt Financing | $3.03M | 1 | — | — | Detail |
Aug 6, 2009 | Series B | $30M | 1 | — | — | Detail |
Nov 15, 2007 | Series A | $90M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Hercules Capital | Yes | Post-IPO Debt |
Nomura International | — | Debt Financing |
Phase4 Ventures | — | Series B |